I now have all the material I need. Let me compile the comprehensive 10-mark PG examination answer.
Approach to a Patient with Pruritus
(10 Marks — 3rd Year Dermatology Postgraduate Theory Examination)
DEFINITION
Pruritus (itch) is an unpleasant cutaneous sensation that provokes the desire to scratch. It is the most common skin-related symptom. When it persists for ≥6 weeks, it is termed chronic pruritus, which has a lifetime prevalence of ~22% in the general population.
CLASSIFICATION (IFSI 2007)
The International Forum for the Study of Itch (IFSI) classifies chronic pruritus into three clinical groups based on skin findings:
| Group | Clinical Features |
|---|
| Group I | Pruritus on inflamed (lesional) skin — primary dermatoses |
| Group II | Pruritus on non-inflamed (non-lesional) skin — systemic/neuropathic/psychogenic |
| Group III | Pruritus with secondary scratch-induced lesions — prurigo nodularis, lichen simplex chronicus |
Etiologic categories: Dermatologic · Systemic · Neurologic · Psychogenic · Mixed · Unknown
HISTORY
A precise, structured history is essential:
1. Characteristics of Itch
- Onset — acute (days–weeks) vs. chronic (≥6 weeks)
- Duration and course — continuous, episodic, progressive
- Location — localized (scalp, anogenital, forearm) vs. generalized
- Severity — Numerical Rating Scale (NRS 0–10) or Visual Analogue Scale (VAS)
- Quality — burning, stinging, tickling (neuropathic); crawling sensation (parasitophobia)
- Time pattern — nocturnal (scabies, AD); aquagenic (polycythemia vera, mastocytosis); postbath
2. Aggravating/Relieving Factors
- Heat, sweating, friction, woolen clothing (AD)
- Water contact (aquagenic pruritus)
- Relief with ice packs (brachioradial pruritus — a neuropathic clue)
- Sunlight exposure (photodermatoses)
3. Associated Symptoms
- Skin rash (nature and distribution)
- Jaundice, dark urine, pale stools → cholestatic disease
- Weight loss, night sweats, lymphadenopathy → lymphoma/malignancy
- Polydipsia, polyuria → diabetes mellitus
- Fatigue, cold intolerance, hair loss → thyroid disease
- Burning/tingling with normal skin → neuropathic
4. Drug History
- Opioids (μ-receptor-mediated itch), ACE inhibitors, hydroxyurea, chloroquine, statins, calcium channel blockers — any recent medication change?
5. Personal & Family History
- Atopy (AD, asthma, allergic rhinitis)
- Chronic kidney disease, liver disease, HIV
6. Social History
- Contacts with similar itch (scabies)
- Travel history (parasitic infestations)
- Occupation (fiberglass dermatitis)
- Pregnancy (intrahepatic cholestasis of pregnancy, pruritic urticarial papules and plaques of pregnancy [PUPPP])
7. Quality of Life
- Sleep disturbance, anxiety, depression (ItchyQol questionnaire)
EXAMINATION
A. Dermatological Examination
Examine skin, scalp, hair, nails, mucous membranes completely in good lighting.
Step 1 — Identify primary lesions:
| Primary lesion | Likely diagnosis |
|---|
| Urticarial wheals | Urticaria |
| Vesicles/bullae | Dermatitis herpetiformis, pemphigoid |
| Eczematous plaques, lichenification (flexural) | Atopic dermatitis |
| Silvery plaques on extensor surfaces | Psoriasis |
| Violaceous polygonal papules | Lichen planus (95% pruritic) |
| Burrows (web spaces, wrists, genitalia) | Scabies |
| Erythroderma + Sézary cells | CTCL/Sézary syndrome |
| Pigmented macules/urticaria factitia | Mastocytosis |
Step 2 — Secondary scratch lesions (when no primary disease identified):
- Excoriations, prurigo papules/nodules, lichenification, hyperpigmented scars, linear streaks
- Their distribution is a clue (e.g., sparing the mid-back "butterfly sign" = notalgia paresthetica; linear dorsolateral forearm = brachioradial pruritus)
Step 3 — Signs of systemic disease:
- Jaundice, hepatosplenomegaly, ascites → hepatic/cholestatic
- Pallor, excoriations without primary lesions + uraemic frost → CKD
- Lymphadenopathy + night sweats → lymphoma
- Thyroid enlargement, exophthalmos, pretibial myxedema → thyroid
- Dermographism → urticaria/mastocytosis
- "Butterfly sign" (mid-back spared in CKD pruritus — patient cannot reach)
INVESTIGATIONS
Initial Baseline Work-up (for generalized pruritus without primary skin lesion):
| Investigation | What it detects |
|---|
| CBC with differential | Eosinophilia (parasites), polycythemia vera, leukemia, lymphoma |
| LFTs + bilirubin | Cholestatic/hepatic pruritus (PBC, hepatitis C) |
| Renal function (BUN, creatinine, eGFR) | CKD-associated pruritus |
| Fasting blood glucose / HbA1c | Diabetic neuropathy |
| TFTs (TSH, T4) | Hyperthyroidism/hypothyroidism |
| Serum iron, ferritin | Iron-deficiency (polycythemia vera workup) |
| HIV serology | HIV-associated itch |
| Chest X-ray | Lymphoma, sarcoidosis |
Second-line Work-up (if initial is normal or guided by suspicion):
| Investigation | Indication |
|---|
| Serum IgE, skin prick tests | Atopy |
| ANA, ANCA | Connective tissue diseases |
| Serum protein electrophoresis | Myeloma, amyloidosis |
| JAK2 V617F mutation / BM biopsy | Polycythemia vera |
| Stool microscopy, serology | Parasitic infestation |
| Skin biopsy (lesional + peri-lesional) | CTCL, dermatitis herpetiformis, pemphigoid, mastocytosis |
| CT chest/abdomen/pelvis | Occult lymphoma/solid malignancy |
| Cervical/lumbar MRI | Neuropathic pruritus (brachioradial pruritus, notalgia paresthetica) |
| ICP (bile acids) in pregnancy | Intrahepatic cholestasis of pregnancy |
Key principle: Chronic progressive generalized pruritus without primary skin lesions should always prompt systemic workup, even though no single clinical feature reliably predicts a systemic etiology.
TREATMENT
I. General / Non-pharmacological Measures
- Identify and treat underlying cause
- Lukewarm baths, avoid hot water (vasodilatory)
- Fragrance-free emollients liberally (restore barrier)
- Cotton clothing; avoid wool/synthetic
- Nail trimming (prevent excoriation)
- Cool environmental temperature, fan
- Avoidance of triggers (irritants, allergens)
II. Topical Therapy
| Drug | Mechanism / Use |
|---|
| Corticosteroids | Reduce skin inflammation (inflamed pruritus); not for non-lesional pruritus |
| Calcineurin inhibitors (tacrolimus, pimecrolimus) | AD, lichen planus — especially face/flexures |
| Capsaicin (0.025–0.1%) | TRPV1 desensitization; CKD pruritus, notalgia paresthetica |
| Topical anaesthetics (lidocaine, EMLA) | Localized pruritus |
| Doxepin cream (5%) | H1+H2 blockade; short-term use; risk of sensitization |
| Menthol (1–3%) | Cooling via TRPM8; symptomatic relief |
| Crotamiton | Scabies + antipruritic |
III. Systemic Therapy
| Drug | Indication / Mechanism |
|---|
| Antihistamines (H1) — cetirizine, hydroxyzine | Histamine-mediated itch (urticaria, allergic dermatoses); sedating agents (hydroxyzine) useful for nocturnal pruritus |
| Gabapentin / Pregabalin | Neuropathic pruritus, CKD pruritus, brachioradial pruritus |
| Mirtazapine (7.5–15 mg nightly) | CTCL pruritus, nocturnal pruritus (H1 + 5-HT3 antagonism) |
| Doxepin (10–75 mg) | H1+H2 + TCA; nocturnal pruritus |
| μ-opioid antagonists (naltrexone, naloxone) | Cholestatic, CKD, CTCL pruritus (central opioid modulation) |
| κ-opioid agonists (nalfurafine, difelikefalin) | CKD pruritus |
| Cholestyramine | Cholestatic pruritus |
| Rifampicin | Cholestatic pruritus (CYP induction) |
| UDCA | Primary biliary cholangitis |
| SSRIs (sertraline, fluvoxamine) | Cholestatic, paraneoplastic pruritus |
| NK1 antagonists (aprepitant) | CTCL, drug-induced pruritus |
| Dupilumab (anti-IL-4Rα) | AD-associated pruritus |
| Nemolizumab (anti-IL-31Rα) | AD and prurigo nodularis |
| Immunosuppressants (ciclosporin, methotrexate) | Severe AD, psoriasis |
IV. Phototherapy
- NB-UVB — CKD pruritus (80–90% response), HIV-associated pruritus, CTCL, prurigo nodularis
- PUVA — aquagenic pruritus, polycythemia vera, CTCL
- UVA-1 — AD, mastocytosis
In CKD pruritus, phototherapy acts systemically — unilateral exposure relieves pruritus bilaterally.
V. Psychological Approaches
- Group psychotherapy, CBT (habit-reversal training)
- Biofeedback, acupuncture
- Treat comorbid anxiety and depression
PREVALENCE SNAPSHOT (Selected Conditions)
| Condition | Pruritus Prevalence |
|---|
| Atopic dermatitis | 100% (diagnostic criterion) |
| Lichen planus | ~95% |
| Psoriasis | 60–95% |
| Primary biliary cholangitis | ~80% |
| Sézary syndrome (CTCL) | >90% |
| End-stage CKD on hemodialysis | 25–45% |
| Polycythemia vera | 30–50% |
| Hodgkin lymphoma | ≤30% |
SUMMARY FLOW
Pruritus
│
├─ Primary skin lesion present?
│ YES → Treat underlying dermatosis
│ NO ↓
│
├─ Thorough history + examination
│
├─ Baseline investigations (CBC, LFT, KFT, TFT, RBS, HIV)
│
├─ Systemic cause found? → Treat cause + symptomatic antipruritic
│
├─ Neuropathic features? → Neuroimaging + gabapentin/pregabalin
│
├─ Psychological cause? → CBT + SSRIs
│
└─ Unknown (15%) → Empirical therapy + longitudinal follow-up
Sources: Dermatology 2-Volume Set 5e (Ständer et al., Ch. 6: Pruritus and Dysesthesia); Fitzpatrick's Dermatology 9e, Ch. on Atopic Dermatitis & Phototherapy.